GATA2 and prostate carcinoma: The present study, however, did not show evidence that AR-mediated signalling in LNCaP cells was among the top pathways affected by GATA2-silencing, indicating that the AR pathway does not constitute a major pathway of GATA2 in prostate cancer metastasis.